Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Testicular Neoplasms 1Oropharyngeal Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Magnetic Resonance Spectroscopy 3Cisplatin 3Carboplatin 3Platinum 2Methods 2Fluorodeoxyglucose F18 2FAPI-46 2Etoposide 2veliparib 1trastuzumab deruxtecan 1sodium thiosulfate 1brodalumab 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Psychology, Positive 1Psychiatric Nursing 1Physical Therapy Modalities 1Paclitaxel 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Interviews as Topic 1Hearing 1Exercise 1Educational Status 1Costs and Cost Analysis 1Blood Specimen Collection 1Bleomycin 1Aspirin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Costs and Cost Analysis × 1 year × Clear all
NCT04531709 2025-07-14

Financial Toxicity and Quality of Life in Patients With TGCT

The University of Texas Health Science Center at San Antonio

Completed
24 enrolled
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡